Speaker illustration

Professor Yong Hoon Kim

Kangwon National University School of Medicine, Chuncheon (Korea (Republic of))

Impact of the gender difference on long-term clinical outcomes in dyslipidemic South Korean AMI patients who underwent PCI with new-generation DES

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute coronary syndrome

Thumbnail

Two-year clinical outcomes between statin with ACE inhibitor or ARB in patients with ST-segment elevation myocardial infarction after successful PCI with DES

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Acute coronary syndromes, coronary artery disease: treatment

Thumbnail

Three-year major clinical outcomes of phosphorylcholine polymer- versus BioLinx polymer-zotarolimus-eluting stents: A propensity score matching study

Event: ESC Congress 2018

Topic: Stents

Session: Coronary interventions

Thumbnail

Angiotensin converting enzyme inhibitor versus angiotensin receptor blockers on the top of calcium channel blocker in development of new-onset diabetes mellitus in hypertensive Korean patients

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Hypertension - Risk profiling and treatment

Thumbnail

Hypertension or diabetes; which is worse prognostic factor for acute coronary syndrome patients following percutaneous coronary intervention?

Event: ESC CONGRESS 2017

Topic: CAD and comorbidities

Session: CAD and comorbidities

Thumbnail

Usefulness of routine angiographic follow-up in diabetic patients following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within korean population

Event: ESC CONGRESS 2017

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Prevention - General

Thumbnail

Five-year clinical outcomes in patients with moderate coronary artery spasm as assessed by intracoronary acetylcholine provocation test

Event: ESC CONGRESS 2016

Topic: Angina pectoris stable

Session: Stable angina - Treatment and outcomes

Thumbnail

This platform is supported by

logo Novo Nordisk